Merck's Januvia, animal health products slump; shares off

By Ransdell Pierson (Reuters) - Merck & Co Inc reported lower sales of its Januvia diabetes treatment, fresh evidence its biggest product is losing ground to newer drugs, and also spooked investors with falling quarterly sales of its animal health products. The company's shares dropped 2.6 percent, or $1.19, to $45.33 in afternoon trading. Merck's animal health brands, which typically prop up results, suffered a 2 percent sales decline in third quarter, hurt by the recent decision to suspend marketing of its Zilmax weight-gain feed supplement amid concerns it was causing lameness in cattle. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/merck-third-quarter-profit-beats-estimate-januvia-sales-111531301--finance.html